Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats

Acta Pharmacologica Sinica

Volumn 26, Issue 7, 2005, Pages 806-812

  Chen, Hong ^a,b   Wu, Xing Jun ^a   Lu, Xi Yuan ^a   Zhu, Liang ^a   Wang, Li Ping ^a   Yang, Huang Tian ^a   Chen, Hong Zhuan ^a   Yuan, Wen Jun ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Heart; Heat shock proteins; Ischemia; Reperfusion; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; ISOPHANE INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SYSTOLE; UPREGULATION; VASODILATATION; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HEART RATE; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HYPERGLYCEMIA; INSULIN; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; VENTRICULAR PRESSURE;

EID: 22144464108     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00113.x     Document Type: Article

References (23)

1. Buse JB. Should postprandial glucose be routinely measured and treated to a particular target? No! Diabetes Care 2003; 26: 1615-8.
2. Balkau B, Forhan A, Eschwege E. Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study. Diabetologia 2002; 45: 1224-30.
3. Jarrett RJ. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease - chicken, egg or neither? Diabetologia 1984; 26: 99-102.
4. Meigs JB, Singer DE, Sullivan LM, Dukes KA, D'Agostino RB, Nathan DM, et al. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med 1997; 102: 38-47.
5. Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 1993; 88: 1273-8.
6. Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, et al. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 2002; 45: 1172-81.
7. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res 1997; 34: 113-20.
8. + exchanger protects diabetic and non-diabetic hearts from ischemic injury: insight into altered susceptibility of diabetic hearts to ischemic injury. J Mol Cell Cardiol 1999; 31: 785-97.
9. 2+ metabolism. Circ Res 1988; 62: 931-40.
10. Aasum E, Hafstad AD, Severson DL, Larsen TS. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 2003; 52: 434-41.
11. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995; 44: 369-74.
12. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37: 1053-9.
13. Weitgasser R, Lechleitner M, Koch T, Galvan G, Muhlmann J, Steiner K, et al. Antibodies to heat shock protein 65 and neopterin levels in patients with type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 2003; 111: 127-31.
14. Curtis MJ, Walker MJ. Quantification of arrhythmia using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 1988; 22: 656-65.
15. Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhoffer A, et al. Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia? Basic Res Cardiol 2001; 96: 160-8.
16. Ramasamy R, Oates PJ, Schaefer S. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes 1997; 46: 292-300.
17. Chen H, Higashino H, Kamenov ZA, Azuma M, Lee WH, Yang XQ, et al. Preserved postischemic heart function in sucrose-fed type 2 diabetic OLETF rats. Life Sci 2003; 72: 2839-51.
18. Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc Res 2001; 51: 637-46.
19. 1 receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 2000; 86: 989-97.
20. Wang LP, Liu T, Chen H, Chen HZ, Gao PJ, Zhu DL. Experimental study on paradoxical phenomenon in type 1 diabetic heart: increased resistance to ischemia/reperfusion injury. Shanghai Med J 2004; 91: 300-6.
21. Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol 1995; 269: H1767-H1775.
22. Chen H, Higashino H, Maeda K, Zhang Z, Ohta Y, Wang Z, et al. Reduction of cardiac norepinephrine improves postischemic heart function in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2001; 38: 821-32.
23. Shen B, Ye CL, Ye KH, Liu JJ, Sun P, Jiang JH. Mechanism underlying enhanced endothelium-dependent vasodilation in thoracic aorta of early stage streptozotocin-induced diabetic mice. Acta Pharmacol Sin 2003; 24: 422-8.